1665. Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test

BACKGROUND: U.S. laboratories are increasingly using a two-step algorithm to diagnose Clostridioides difficile infection (CDI) that starts with a nucleic acid amplification test (NAAT), and if positive, reflexes to a toxin enzyme immunoassay. Here only a NAAT+/toxin+ result is reported to the Center...

Descripción completa

Detalles Bibliográficos
Autores principales: Guh, Alice, Winston, Lisa Gail, Johnston, Helen, Basiliere, Elizabeth, Olson, Danyel M, Fridkin, Scott, Goodenough, Dana, Wilson, Christopher, Watkins, Jasmine, Korhonen, Lauren C, Gerding, Dale N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751601/
http://dx.doi.org/10.1093/ofid/ofac492.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751601/
http://dx.doi.org/10.1093/ofid/ofac492.131

Ejemplares similares